propargylamine

monoamine oxidase B ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35447344 The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase. 2022 Jul 1 1
2 34281458 Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents. 2021 Dec 1
3 30108930 Design, synthesis and evaluation of indole derivatives as multifunctional agents against Alzheimer's disease. 2018 Feb 1 3
4 26999091 Searching for Multi-Targeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif. 2016 Mar 17 1
5 27396685 Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors. 2016 Oct 15 1
6 23211968 Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity. 2013 Jan 1 3
7 23908775 Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential. 2010 Jul 1
8 18035186 Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. 2007 Sep 1
9 18488080 Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy. 2007 Jun 1
10 16675649 Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson's disease. 2006 May 15 2
11 17017568 Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety. 2006 1
12 16027398 Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease. 2005 Aug 2
13 14696044 Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease? 2004 Jan 2
14 7931256 Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications. 1994 1
15 8469735 [An increase in the radioprotective effect of O-methyltyramine and mezaton by monoamine oxidase inhibitors]. 1993 Jan-Feb 1